cFluor® R720 Anti-Human CD16 (3G8)
View Cart or Continue shopping.
The 3G8 monoclonal antibody binds to IgG receptor III (FcγRIII) that are in two forms: CD16a ((FcγRIIIA) and CD16b ((FcγRIIIB). With 95% sequence similarity, they are a conventional 50-65 kD polypeptide-anchored transmembrane protein and a 48 kD GPI-anchored protein, respectively. CD16a is expressed on NK cells and macrophages while CD16b is expressed on neutrophils1,2. CD16a also plays a crucial role for antibody-dependent cellular cytotoxicity (ADCC) by NK cells3. The antibody was conjugated to a fluorophore and puriﬁed by afﬁnity chromatography.
Reactivity: Human, Baboon, Capuchin Monkey, Chimpanzee, Common Marmoset, Cynomolgus, Pigtailed Macaque, Rhesus, Sooty Mangabey, Squirrel Monkey
Format: cFluor® R7201
Isotype: Mouse IgG1, κ
Tested Dilution: 5 μL / test
Application: Flow Cytometry
Storage: 2-8°C and protected from Light. Do not freeze.
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide and 0.2% BSA (BSA Country of Origin USA).
- Wirthmueller U, et al. 1992. J Exp Med. 175:1381
- Smed-Sörensen A, et al. 2008. Blood. 111:5037
- Wei H Y, et al, 2016. Sci Rep. 6:34310
This product is intended for in vitro diagnostic use to identify human cells expressing CD16 antigen molecules in countries where the regulatory approval has been obtained from the local regulatory authorities.
1cFluor® R720 is equivalent to CF®700 manufactured and provided by Biotium, Inc. under an Agreement between Biotium and Cytek (LICENSEE). The manufacture, use, sale, offer for sale, or import of the product is covered by one or more of the patents or pending applications owned or licensed by Biotium. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser’s own internal research. No right under any other patent claim, no right to perform any patented method, and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel.